Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Deciphera Pharmaceuticals, LLC
INSYS Therapeutics Inc
National Cancer Institute (NCI)
University of Alberta
Case Comprehensive Cancer Center